Trade Mark Journal No.2026/025 19 June 2026
WO0000001842873 (5,42,44)
Office of origin: United States of America
Date of International Registration:28 January 2025
Date of designation in the UK:
21 February 2026
Registration of this mark shall not give right to the exclusive use of "THERAPEUTICS".
- Class 5
- Pharmaceutical preparations for use in the treatment of malignancies; pharmaceutical preparations, namely, antitumor agents; pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of cancer and for use in oncology and immuno-oncology.
- Class 42
- Drug discovery services for the identification and analysis of therapeutics for use in oncology and immuno-oncology; research and development services in the field of therapeutics for the treatment of cancer; research and development services in the fields of oncology and immuno-oncology; providing medical and scientific research information in the field of biopharmaceuticals; providing medical and scientific research information in the field of cancer.
- Class 44
- Healthcare services, namely, providing patient treatment services in the fields of oncology and immuno-oncology; provision of medical services in the field of oncology and immuno-oncology for the treatment of patients; advice relating to oncology and immuno-oncology; providing medical care services in the field of oncology and immuno-oncology; providing medical information in the field of cancer; medical counseling in the field of oncology and immuno-oncology; clinical medical consulting in the field of oncology and immuno-oncology.
SUMMIT THERAPEUTICS SUB INC.
Representative: Andrea M. Porterfield Polsinelli PC, PO Box 140310, Kansas City MO 64114-0310, UNITED STATES OF AMERICA